Patent · US Active

Bromodomain inhibitors

US9957263B2 · kind B2 · utility

2Cited by

0References

5Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Yujia Dai · Gurnee, US
Steven D. Fidanze · Grayslake, US
Lisa A. Hasvold · Grayslake, US
James H. Holms · Gurnee, US
Dachun Liu · Vernon Hills, US
William J. McClellan · Waukegan, US
Keith F. McDaniel · Wauconda, US
Jasmina Marjanovic · Chicago, US
George S. Sheppard · Wilmette, US
Le Wang · Xi'an, CN

Key dates

Filing date	Jun 27, 2014
Grant date	May 1, 2018
Priority date	—
Expiry date	Jun 27, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided. The compounds are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Pharmaceutical compositions comprised of one or more compounds of formula (I) are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.